Brown, T. A., Byrd, K., Vreeland, T. J., Clifton, G. T., Jackson, D. O., Hale, D. F., Herbert, G. S., Myers, J. W., Greene, J. M., Berry, J. S., Martin, J., Elkas, J. C., Conrads, T. P., Darcy, K. M., Hamilton, C. A., Maxwel, G. L., & Peoples, G. E. (n.d.). final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. Cancer medicine, 8, 4678–4687. http://access.bl.uk/ark:/81055/vdc_100091289199.0x000013